FilingSEC EDGAR8-K
Emergent BioSolutions Secures $24 Million Contract Modification for Anthrax Vaccine
· SEC accepted
StageContract Award
Filing content
The company entered into a $24 million contract modification with BARDA to supply additional doses of its CYFENDUS anthrax vaccine.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…